We are live on ! Find out more
BIM

BlackRock Investment Management Portfolio holdings

AUM $86.4B
1-Year Est. Return 28.54%
This Fund
S&P 500
This Quarter Est. Return
+15.87%
1 Year Est. Return
+28.54%
3 Year Est. Return
+50.87%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$81.4B
AUM Growth
+$2.32B
Cap. Flow
-$2.14B
Cap. Flow %
-2.64%
Top 10 Hldgs %
14.09%
Holding
4,126
New
79
Increased
1,674
Reduced
1,700
Closed
176

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$185M
2
BIIB icon
Biogen
BIIB
+$118M
3
CHTR icon
Charter Communications
CHTR
+$86.1M
4
AVGO icon
Broadcom
AVGO
+$83.5M
5
ROP icon
Roper Technologies
ROP
+$79.5M

Top Sells

Rank Stock Value
1
TTE icon
TotalEnergies
TTE
+$1.28B
2
INTC icon
Intel
INTC
+$164M
3
EMC
EMC CORPORATION
EMC
+$111M
4
MCD icon
McDonald's
MCD
+$90.2M
5
AGN
Allergan plc
AGN
+$88.1M

Sector Composition

Rank Sector Weight
1 Financials 15.37%
2 Healthcare 14.6%
3 Technology 13.59%
4 Industrials 9.57%
5 Consumer Discretionary 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBRX icon
3051
ImmunityBio
IBRX
$8.2B
$496K ﹤0.01%
63,701
-142
-0.2% -$1.06K
LFVN icon
3052
LifeVantage
LFVN
$82.1M
$494K ﹤0.01%
52,199
-94
-0.2% -$1.22K
CDTX
3053
DELISTED
Cidara Therapeutics
CDTX
$493K ﹤0.01%
2,154
-5
-0.2% -$1.16K
GUID
3054
DELISTED
Guidance Software, Inc.
GUID
$493K ﹤0.01%
82,707
-159
-0.2% -$944
ECYT
3055
DELISTED
Endocyte, Inc. Common Stock
ECYT
$492K ﹤0.01%
159,176
-729
-0.5% -$2.27K
QNST icon
3056
QuinStreet
QNST
$1.19B
$490K ﹤0.01%
162,203
-2,771
-2% -$9.34K
RGLS
3057
DELISTED
Regulus Therapeutics
RGLS
$489K ﹤0.01%
1,236
-1
-0.1% -$411
OCUL icon
3058
Ocular Therapeutix
OCUL
$2.25B
$486K ﹤0.01%
70,728
+9,255
+15% +$56.4K
FCFP
3059
DELISTED
FIRST COMMUNITY FINANCIAL PARTNERS INC.
FCFP
$486K ﹤0.01%
51,050
+1,051
+2% +$9.5K
DLA
3060
DELISTED
Delta Apparel Inc.
DLA
$485K ﹤0.01%
29,486
-38
-0.1% -$765
TOVX icon
3061
Theriva Biologics
TOVX
$10.6M
$484K ﹤0.01%
32
– –
ANAT
3062
DELISTED
American National Group, Inc. Common Stock
ANAT
$484K ﹤0.01%
3,965
+263
+7% +$30.4K
RILY icon
3063
BRC Group Holdings
RILY
$304M
$483K ﹤0.01%
36,527
+196
+0.5% +$1.99K
AMRC icon
3064
Ameresco
AMRC
$1.47B
$480K ﹤0.01%
91,181
-353
-0.4% -$1.75K
ANTH
3065
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$480K ﹤0.01%
19,043
+7
+0% +$177
BSAC icon
3066
Banco Santander Chile
BSAC
$16B
$478K ﹤0.01%
23,110
+19,604
+559% +$409K
DCOY
3067
Decoy Therapeutics
DCOY
$1.92M
– –
0
– –
AGTC
3068
DELISTED
Applied Genetic Technologies Corporation
AGTC
$476K ﹤0.01%
48,674
-80
-0.2% -$1.08K
LILA icon
3069
Liberty Latin America Class A
LILA
$1.69B
$473K ﹤0.01%
26,791
-719,324
-96% -$14.2M
IMH
3070
DELISTED
Impac Mortgage Holdings Inc.
IMH
$471K ﹤0.01%
35,677
-114
-0.3% -$1.85K
III icon
3071
Information Services Group
III
$249M
$470K ﹤0.01%
117,762
-332
-0.3% -$1.28K
MOBL
3072
DELISTED
MobileIron, Inc.
MOBL
$469K ﹤0.01%
170,424
-302
-0.2% -$933
AGFS
3073
DELISTED
AgroFresh Solutions Inc
AGFS
$467K ﹤0.01%
88,195
-89
-0.1% -$518
NNA
3074
DELISTED
Navios Maritime Acquisition Corporation
NNA
$462K ﹤0.01%
22,797
-82
-0.4% -$1.81K
AVXL icon
3075
Anavex Life Sciences
AVXL
$316M
$460K ﹤0.01%
126,696
-326
-0.3% -$1.37K
121 122
123
124 125

Similar funds

BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
BJ
BlackRock Japan Tokyo, Japan $30.3B AUM 13.85% 1-Year Est. Return
IC
Institutional Capital Chicago, Illinois $6.75B AUM 3.51% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
MFS
MSI Financial Services Springfield, Massachusetts $3.07B AUM 12.48% 1-Year Est. Return
CIM
Calvert Investment Management Bethesda, Maryland $2.67B AUM 18.2% 1-Year Est. Return
KAM
Keeley Asset Management Chicago, Illinois $2.35B AUM 26.92% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $1.69B AUM 8.84% 1-Year Est. Return

BlackRock Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, BlackRock Investment Management held 4,126 positions worth $81.4B, up 2.9% from $79B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Investment Management's Q3 2016 filing shows 79 new, 1,674 increased, 1,700 reduced and 176 closed positions. Its largest new stake was Fortive: 900,865 shares worth $28.9M. The largest sale was TotalEnergies, an estimated $1.28B.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

  • BlackRock Investment Management's largest Q3 2016 buy was Fortive: 900,865 shares worth $28.9M.
  • BlackRock Investment Management added most to Alexion Pharmaceuticals in Q3 2016, an estimated $185M increase.
  • BlackRock Investment Management's biggest Q3 2016 reduction was TotalEnergies, cutting an estimated $1.28B.
  • BlackRock Investment Management fully exited EMC CORPORATION in Q3 2016, selling an estimated $111M.
  • BlackRock Investment Management's ten largest holdings make up 14% of its $81.4B portfolio in Q3 2016.
  • BlackRock Investment Management opened 79 new positions and closed 176 in Q3 2016.
  • BlackRock Investment Management's portfolio value rose 2.9% quarter-over-quarter to $81.4B.

Based on BlackRock Investment Management's 13F filing for Q3 2016, filed 8 Nov 2016.